niacin has been researched along with Diabetic Retinopathy in 7 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
Excerpt | Relevance | Reference |
---|---|---|
"Dyslipidemia is an important risk factor for cardiovascular complications in persons with diabetes." | 2.47 | Treatment approaches for diabetes and dyslipidemia. ( Lyons, TJ; Wu, M, 2011) |
"Early diabetic retinopathy is characterized by a loss of pericytes and vascular endothelial cells, a breakdown of the blood-retinal barrier, vascular dysfunction and vascular-neuroinflammation." | 1.43 | MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy. ( Wang, Y; Yan, H, 2016) |
"Excellent results were obtained in the treatment of macular edema following cataract surgery and in older patients with diabetic retinopathy." | 1.24 | PERIPHERAL VASODILATORS IN THE TREATMENT OF MACULAR DEGENERATIVE CHANGES IN THE EYE. ( LAWS, HW, 1964) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yu, AL | 1 |
Birke, K | 1 |
Lorenz, RL | 1 |
Welge-Lussen, U | 1 |
Graff, EC | 1 |
Fang, H | 1 |
Wanders, D | 1 |
Judd, RL | 1 |
Wang, Y | 1 |
Yan, H | 1 |
Wu, M | 1 |
Lyons, TJ | 1 |
Gambhir, D | 1 |
Ananth, S | 1 |
Veeranan-Karmegam, R | 1 |
Elangovan, S | 1 |
Hester, S | 1 |
Jennings, E | 1 |
Offermanns, S | 1 |
Nussbaum, JJ | 1 |
Smith, SB | 1 |
Thangaraju, M | 1 |
Ganapathy, V | 1 |
Martin, PM | 1 |
KOJIMA, K | 1 |
LAWS, HW | 1 |
2 reviews available for niacin and Diabetic Retinopathy
Article | Year |
---|---|
Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2.
Topics: Animals; Atherosclerosis; Colitis; Diabetic Retinopathy; Humans; Inflammation; Mice; Neoplasms; Neur | 2016 |
Treatment approaches for diabetes and dyslipidemia.
Topics: Apolipoprotein B-100; Cholesterol, HDL; Cholesterol, LDL; Diabetes Complications; Diabetes Mellitus; | 2011 |
5 other studies available for niacin and Diabetic Retinopathy
Article | Year |
---|---|
Constitutive expression of HCA(2) in human retina and primary human retinal pigment epithelial cells.
Topics: 3-Hydroxybutyric Acid; Adult; Cell Line; Diabetic Retinopathy; Eye Banks; Humans; Immunohistochemist | 2014 |
MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy.
Topics: Angiogenesis Inducing Agents; Angiogenic Proteins; Animals; Apoptosis; Ascorbic Acid; Blood Glucose; | 2016 |
GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy.
Topics: 3-Hydroxybutyric Acid; Aged; Animals; Cell Line; Chemokine CCL2; Diabetes Mellitus, Experimental; Di | 2012 |
[DIABETES MELLITUS AND EYE CHANGES].
Topics: Adenosine Triphosphate; Animals; Blood Pressure Determination; Diabetes Mellitus, Experimental; Diab | 1963 |
PERIPHERAL VASODILATORS IN THE TREATMENT OF MACULAR DEGENERATIVE CHANGES IN THE EYE.
Topics: Aged; Blood Flow Velocity; Blood Volume; Cataract Extraction; Choroid; Diabetic Retinopathy; Drug Th | 1964 |